Clinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance

Anthony V. Pensa; Veronica Zheng; Lucia Davis; Rebecca W. Harap; Jane E. Wilcox

doi:10.14797/mdcvj.1441

Clinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance

Methodist DeBakey Cardiovascular Journal

Volume 20 (2024): Issue 4

By: Anthony V. Pensa , Veronica Zheng , Lucia Davis , Rebecca W. Harap and Jane E. Wilcox

Open Access

|Aug 2024

Hellawell JL, Margulies KB. Myocardial Reverse Remodeling. Cardiovasc Ther. 2012 Nov 25;30(3):172-181. doi: 10.1111/j.1755-5922.2010.00247.x
Open DOI Search in Google Scholar Back to article
Givertz MM, Mann DL. Epidemiology and Natural History of Recovery of Left Ventricular Function in Recent Onset Dilated Cardiomyopathies. Curr Heart Fail Rep. 2013 Dec;10(4):321-330. doi: 10.1007/s11897-013-0157-5
Open DOI Search in Google Scholar Back to article
Mann DL, Burkhoff D. Is Myocardial Recovery Possible and How Do You Measure It? Curr Cardiol Rep. 2012 Jun;14(3):293-298. doi: 10.1007/s11886-012-0264-z
Open DOI Search in Google Scholar Back to article
Scally C, Rudd A, Mezincescu A, et al. Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy. Circulation. 2018 Mar 6;137(10):1039-1048. doi: 10.1161/CIRCULATIONAHA.117.031841
Open DOI Search in Google Scholar Back to article
Hnat T, Veselka J, Honek J. Left Ventricular Reverse Remodelling and Its Predictors in Non-Ischaemic Cardiomyopathy. ESC Heart Fail. 2022 Aug;9(4):2070-2083. doi: 10.1002/ehf2.13939
Open DOI Search in Google Scholar Back to article
Boulet J, Mehra MR. Left Ventricular Reverse Remodeling in Heart Failure: Remission to Recovery. Structural Heart. 2021 Sep;5(5):466-481. doi: 10.1080/24748706.2021.1954275
Open DOI Search in Google Scholar Back to article
Birks EJ, Drakos SG, Patel SR, et al. Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results. Circulation. 2020 Nov 24;142(21):2016-2028. doi: 10.1161/CIRCULATIONAHA.120.046415
Open DOI Search in Google Scholar Back to article
Nauta JF, Santema BT, van der Wal MHL, et al. Improvement in Left Ventricular Ejection Fraction After Pharmacological Up-Titration in New-Onset Heart Failure with Reduced Ejection Fraction. Neth Heart J. 2021 Jul;29(7-8):383-393. doi: 10.1007/s12471-021-01591-6
Open DOI Search in Google Scholar Back to article
Florea VG, Rector TS, Anand IS, Cohn JN. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial. Circ Heart Fail. 2016 Jul;9(7):e003123. doi: 10.1161/CIRCHEARTFAILURE.116.003123
Open DOI Search in Google Scholar Back to article
Brambatti M, Guerra F, Matassini MV, et al. Cardiac Resynchronization Therapy Improves Ejection Fraction and Cardiac Remodelling Regardless of Patients’ Age. EP Europace. 2013 May;15(5):704-710. doi: 10.1093/europace/eus376
Open DOI Search in Google Scholar Back to article
Antonio N, Teixeira R, Coelho L, et al. Identification of ‘Super-Responders’ to Cardiac Resynchronization Therapy: The Importance of Symptom Duration and Left Ventricular Geometry. Europace. 2009 Mar;11(3):343-349. doi: 10.1093/europace/eup038
Open DOI Search in Google Scholar Back to article
Linde C, Abraham WT, Gold MR, et al. Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients with Left Ventricular Dysfunction and Previous Heart Failure Symptoms. J Am Coll Cardiol. 2008 Dec 2;52(23):1834-1843. doi: 10.1016/j.jacc.2008.08.027
Open DOI Search in Google Scholar Back to article
St John Sutton MG, Plappert T, Abraham WT, et al. Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure. Circulation. 2003 Apr 22;107(15):1985-1990. doi: 10.1161/01.CIR.0000065226.24159.E9
Open DOI Search in Google Scholar Back to article
Wilcox JE, Fang JC, Margulies KB, Mann DL. Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel. J Am Coll Cardiol. 2020 Aug 11;76(6):719-734. doi: 10.1016/j.jacc.2020.05.075
Open DOI Search in Google Scholar Back to article
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/cir.0000000000001063
Open DOI Search in Google Scholar Back to article
Bozkurt B, Coats AJS, Tsutsui H, et al. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021 Mar;23(3):352-380. doi: 10.1002/ejhf.2115
Open DOI Search in Google Scholar Back to article
Gulati G, Udelson JE. Heart Failure with Improved Ejection Fraction: Is It Possible to Escape One’s Past? JACC Heart Fail. 2018 Sep;6(9):725-733. doi: 10.1016/j.jchf.2018.05.004
Open DOI Search in Google Scholar Back to article
Cioffi G, Stefenelli C, Tarantini L, Opasich C. Chronic Left Ventricular Failure in the Community: Prevalence, Prognosis, and Predictors of the Complete Clinical Recovery with Return of Cardiac Size and Function to Normal in Patients Undergoing Optimal Therapy. J Card Fail. 2004 Jun;10(3):250-257. doi: 10.1016/j.cardfail.2003.10.002
Open DOI Search in Google Scholar Back to article
McNamara DM, Starling RC, Cooper LT, et al. Clinical and Demographic Predictors of Outcomes in Recent Onset Dilated Cardiomyopathy: Results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 Study. J Am Coll Cardiol. 2011 Sep 6;58(11):1112-1118. doi: 10.1016/j.jacc.2011.05.033
Open DOI Search in Google Scholar Back to article
Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G. Prevalence and Prognostic Significance of Left Ventricular Reverse Remodeling in Dilated Cardiomyopathy Receiving Tailored Medical Treatment. J Am Coll Cardiol. 2011 Mar 29;57(13):1468-1476. doi: 10.1016/j.jacc.2010.11.030
Open DOI Search in Google Scholar Back to article
Wilcox JE, Fonarow GC, Yancy CW, et al. Factors Associated with Improvement in Ejection Fraction in Clinical Practice Among Patients with Heart Failure: Findings from IMPROVE HF. Am Heart J. 2012 Jan;163(1):49-56 e2. doi: 10.1016/j.ahj.2011.10.001
Open DOI Search in Google Scholar Back to article
Dunlay SM, Roger VL, Weston SA, Jiang R, Redfield MM. Longitudinal Changes in Ejection Fraction in Heart Failure Patients with Preserved and Reduced Ejection Fraction. Circ Heart Fail. 2012 Nov;5(6):720-726. doi: 10.1161/CIRCHEARTFAILURE.111.966366
Open DOI Search in Google Scholar Back to article
Basuray A, French B, Ky B, et al. Heart Failure with Recovered Ejection Fraction: Clinical Description, Biomarkers, and Outcomes. Circulation. 2014 Jun 10;129(23):2380-2387. doi: 10.1161/CIRCULATIONAHA.113.006855
Open DOI Search in Google Scholar Back to article
Merlo M, Stolfo D, Anzini M, et al. Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long-term follow-up: does real healing exist? J Am Heart Assoc. 2015 Jan 13;4(1):e001504. doi: 10.1161/JAHA.114.000570
Open DOI Search in Google Scholar Back to article
Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, et al. Characteristics and Outcomes of Adult Outpatients with Heart Failure and Improved or Recovered Ejection Fraction. JAMA Cardiol. 2016 Aug 1;1(5):510-518. doi: 10.1001/jamacardio.2016.1325
Open DOI Search in Google Scholar Back to article
Lupón J, Diez-Lopez C, de Antonio M, et al. Recovered Heart Failure with Reduced Ejection Fraction and Outcomes: A Prospective Study. Eur J Heart Fail. 2017 Dec;19(12):1615-1623. doi: 10.1002/ejhf.824
Open DOI Search in Google Scholar Back to article
Agra Bermejo R, Gonzalez Babarro E, Lopez Canoa JN, et al. Heart Failure with Recovered Ejection Fraction: Clinical Characteristics, Determinants and Prognosis. CARDIOCHUS-CHOP Registry. Cardiol J. 2018;25(3):353-362. doi: 10.5603/CJ.a2017.0103
Open DOI Search in Google Scholar Back to article
Chang KW, Beri N, Nguyen NH, et al. Heart Failure with Recovered Ejection Fraction in African Americans: Results from the African-American Heart Failure Trial. J Card Fail. 2018 May;24(5):303-309. doi: 10.1016/j.cardfail.2017.09.005
Open DOI Search in Google Scholar Back to article
Ghimire A, Fine N, Ezekowitz JA, Howlett J, Youngson E, McAlister FA. Frequency, Predictors, and Prognosis of Ejection Fraction Improvement in Heart Failure: An Echocardiogram-Based Registry Study. Eur Heart J. 2019 Jul 1;40(26):2110-2117. doi: 10.1093/eurheartj/ehz233
Open DOI Search in Google Scholar Back to article
He Y, Ling Y, Guo W, et al. Prevalence and Prognosis of HFimpEF Developed from Patients with Heart Failure with Reduced Ejection Fraction: Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2021 Nov 25;8:757596. doi: 10.3389/fcvm.2021.757596
Open DOI Search in Google Scholar Back to article
Zhang X, Sun Y, Zhang Y, et al. Characteristics and Outcomes of Heart Failure with Recovered Left Ventricular Ejection Fraction. ESC Heart Fail. 2021 Dec;8(6):5383-5391. doi: 10.1002/ehf2.13630
Open DOI Search in Google Scholar Back to article
Yang CD, Pan WQ, Feng S, et al. Insulin Resistance Is Associated with Heart Failure with Recovered Ejection Fraction in Patients Without Diabetes. J Am Heart Assoc. 2022 Oct 4;11(19):e026184. doi: 10.1161/JAHA.122.026184
Open DOI Search in Google Scholar Back to article
Goh ZM, Javed W, Shabi M, et al. Early Prediction of Left Ventricular Function Improvement in Patients with New-Onset Heart Failure and Presumed Non-Ischaemic Aetiology. Open Heart. 2023;10(2):e002429. doi: 10.1136/openhrt-2023-002429
Open DOI Search in Google Scholar Back to article
Liu D, Hu K, Schregelmann L, et al. Determinants of Ejection Fraction Improvement in Heart Failure Patients with Reduced Ejection Fraction. ESC Heart Fail. 2023 Aug;10(2):1358-1371. doi: 10.1002/ehf2.14303
Open DOI Search in Google Scholar Back to article
Romero E, Baltodano AF, Rocha P, et al. Clinical, Echocardiographic, and Longitudinal Characteristics Associated with Heart Failure with Improved Ejection Fraction. Am J Cardiol. 2024 Jan 15;211:143-152. doi: 10.1016/j.amjcard.2023.10.086
Open DOI Search in Google Scholar Back to article
Mohebi R, Liu Y, Felker GM, et al. Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan. JACC Heart Fail. 2023 Jan;11(1):44-54. doi: 10.1016/j.jchf.2022.09.009
Open DOI Search in Google Scholar Back to article
Jackson AM, Goland S, Farhan HA, et al. A Novel Score to Predict Left Ventricular Recovery in Peripartum Cardiomyopathy Derived from the ESC EORP Peripartum Cardiomyopathy Registry. Eur Heart J. 2024 Apr 21;45(16):1430-1439. doi: 10.1093/eurheartj/ehad888
Open DOI Search in Google Scholar Back to article
Cooper LT, Mather PJ, Alexis JD, et al. Myocardial Recovery in Peripartum Cardiomyopathy: Prospective Comparison with Recent Onset Cardiomyopathy in Men and Nonperipartum Women. J Card Fail. 2012 Jan;18(1):28-33. doi: 10.1016/j.cardfail.2011.09.009
Open DOI Search in Google Scholar Back to article
Dominguez F, Adler E, Garcia-Pavia P. Alcoholic cardiomyopathy: an update. Eur Heart J. 2024 Jul 9;45(26):2294-2305. doi: 10.1093/eurheartj/ehae362
Open DOI Search in Google Scholar Back to article
Ewer MS, Vooletich MT, Durand JB, et al. Reversibility of Trastuzumab-Related Cardiotoxicity: New Insights Based on Clinical Course and Response to Medical Treatment. J Clin Oncol. 2005 Nov 1;23(31):7820-7826. doi: 10.1200/JCO.2005.13.300
Open DOI Search in Google Scholar Back to article
Amor-Salamanca A, Guzzo-Merello G, Gonzalez-Lopez E, et al. Prognostic Impact and Predictors of Ejection Fraction Recovery in Patients With Alcoholic Cardiomyopathy. Rev Esp Cardiol (Engl Ed). 2018 Aug;71(8):612-619. doi: 10.1016/j.rec.2017.11.032
Open DOI Search in Google Scholar Back to article
Halliday BP, Wassall R, Lota AS, et al. Withdrawal of Pharmacological Treatment for Heart Failure in Patients with Recovered Dilated Cardiomyopathy (TRED-HF): An Open-Label, Pilot, Randomised Trial. Lancet. 2019 Jan 5;393(10166):61-73. doi: 10.1016/S0140-6736(18)32484-X
Open DOI Search in Google Scholar Back to article
Negi PC, Gupta A, Thakur P, et al. Incidence, Determinants, and Outcomes of Recovered Left Ventricular Ejection Fraction (LVEF) in Patients with Non-Ischemic Systolic Heart Failure: A Hospital-Based Cohort Study. Indian Heart J. 2023 Mar-Apr;75(2):128-132. doi: 10.1016/j.ihj.2023.02.003
Open DOI Search in Google Scholar Back to article
Manca P, Stolfo D, Merlo M, et al. Transient Versus Persistent Improved Ejection Fraction in Non-Ischaemic Dilated Cardiomyopathy. Eur J Heart Fail. 2022 Jul;24(7):1171-1179. doi: 10.1002/ejhf.2512
Open DOI Search in Google Scholar Back to article
Januzzi JL Jr., Prescott MF, Butler J, et al. Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment with Cardiac Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction. JAMA. 2019 Sep 17;322(11):1085-1095. doi: 10.1001/jama.2019.12821
Open DOI Search in Google Scholar Back to article
Pensa AV, Khan SS, Shah RV, Wilcox JE. Heart Failure with Improved Ejection Fraction: Beyond Diagnosis to Trajectory Analysis. Prog Cardiovasc Dis. 2024 Jan-Feb;82:102-112. doi: 10.1016/j.pcad.2024.01.014
Open DOI Search in Google Scholar Back to article
Janwanishstaporn S, Cho JY, Feng S, et al. Prognostic Value of Global Longitudinal Strain in Patients with Heart Failure with Improved Ejection Fraction. JACC Heart Fail. 2022 Jan;10(1):27-37. doi: 10.1016/j.jchf.2021.08.007
Open DOI Search in Google Scholar Back to article
Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286
Open DOI Search in Google Scholar Back to article
Vardeny O, Fang JC, Desai AS, et al. Dapagliflozin in Heart Failure with Improved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial. Nat Med. 2022 Dec;28(12):2504-2511. doi: 10.1038/s41591-022-02102-9
Open DOI Search in Google Scholar Back to article
Vardeny O, Desai AS, Jhund PS, et al. Dapagliflozin and Mode of Death in Heart Failure with Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER Trial. JAMA Cardiol. 2024 Mar 1;9(3):283-289. doi: 10.1001/jamacardio.2023.5318
Open DOI Search in Google Scholar Back to article
Nesti L, Pugliese NR, Sciuto P, et al. Effect of Empagliflozin on Left Ventricular Contractility and Peak Oxygen Uptake in Subjects with Type 2 Diabetes Without Heart Disease: Results of the EMPA-HEART Trial. Cardiovasc Diabetol. 2022 Sep 12;21(1):181. doi: 10.1186/s12933-022-01618-1
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.14797/mdcvj.1441 | Journal eISSN: 1947-6108

Journal RSS Feed

Language: English

Page range: 6 - 15

Submitted on: Jul 1, 2024

Accepted on: Jul 3, 2024

Published on: Aug 20, 2024

Published by: Houston Methodist DeBakey Heart & Vascular Center

In partnership with: Paradigm Publishing Services

Keywords:

myocardial improvement,

myocardial recovery,

heart failure with improved ejection fraction,

left ventricular reverse remodeling,

heart failure trajectory

© 2024 Anthony V. Pensa, Veronica Zheng, Lucia Davis, Rebecca W. Harap, Jane E. Wilcox, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.

Volume 20 (2024): Issue 4